Evidence map›Paper›PMID 38213779›Full record

ArticleHealth science reports2024

Hyperglycemia and elevated C-reactive protein are independent predictors of hospital mortality in hospitalized COVID-19 patients in South-Kivu, eastern Democratic Republic of the Congo: A cross-sectional study.

Christian Tshongo, Marius Baguma, Guy-Quesney Mateso, Samuel Lwamushi Makali, Aline Bedha, Pacifique Mwene-Batu, Martine Mihigo, Fabrice Nzabara, Cordule Balola, Pierre Kabuya and 6 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Christian TshongoFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Marius BagumaFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.ORCID 0000-0002-4934-4846
Guy-Quesney MatesoDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Samuel Lwamushi MakaliDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Aline BedhaFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Pacifique Mwene-BatuFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Martine MihigoDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Fabrice NzabaraDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Cordule BalolaDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Pierre KabuyaDepartment of Internal Medicine Hôpital Provincial Général de Référence de Bukavu (HPGRB) Bukavu Democratic Republic of the Congo.
Achille BapolisiFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Mannix I MasimangoFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Esto BahizireFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Ghislain Maheshe-BalembaFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Tony A ShindanoFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.ORCID 0000-0002-4473-8088
Cikomola CirhuzaFaculty of Medicine Université Catholique de Bukavu (UCB) Bukavu Democratic Republic of the Congo.
Université Catholique de Bukavu · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The coronavirus disease 2019 (COVID-19) pandemic was a priority public health problem because of its high mortality rate. This study mainly aimed to determine factors associated with a poor outcome in COVID-19 hospitalized patients in South-Kivu, an eastern province of the Democratic Republic of the Congo (DRC). Methods: This observational study retrospectively evaluated medical records of patients consecutively admitted for probable or confirmed COVID-19 between May 01 and July 31, 2020 at the Hôpital Provincial Général de Référence de Bukavu (HPGRB), a tertiary hospital located in South-Kivu. A binary logistic regression model was performed to determine the predictors of mortality. Results: A total of 157 hospitalized COVID-19 patients aged 57.7 (13.2) years were included in this study. Male gender (69.4%), older age (52.9%), medical history of diabetes (38.2%), and arterial hypertension (35.1%) were the most frequent risk factors. Most patients presented with fever (73.3%), cough (72.6%), and dyspnea (66.2%). Overall, 45.1% of patients died. Intrahospital mortality was significantly associated with advanced age [odds ratio, OR (95% confidence interval, CI) = 2.34 (1.06-5.38)], hypoxemia [OR (95% CI) = 4.67 (2.02-10.77)], hyperglycemia [OR (95% CI) = 2.14 (1.06-4.31)], kidney failure [OR (95% CI) = 2.82 (1.4-5.68)], hyperleukocytosis [OR (95% CI) = 3.33 (1.67-6.66)], and higher C-reactive protein (CRP) levels [OR (95% CI) = 3.93 (1.93-8.01)]. After adjustment for various covariates, only higher CRP levels [OR (95% CI) = 3.23 (1.23-8.5)] and hyperglycemia [OR (95% CI) = 2.5 (1.02-6.11)] at admission were independently associated with mortality. Conclusion: Hyperglycemia and marked inflammatory syndrome were the major predictors of poor outcomes in patients hospitalized for COVID-19 in South-Kivu. These two factors should be quantified at hospital admission to establish the patient's prognosis.

Indexed as

COVID‐19hospital mortalityhyperglycemiainflammationprognosisSouth‐Kivu

Identifiers

PMID38213779
PMCPMC10782469
OpenAlexW4390741101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.